Skip to main content
Clinical Trials/NL-OMON51836
NL-OMON51836
Recruiting
Not Applicable

INflammation and cerebral small vessel disease (INSVD) study - INSVD

Radboud Universitair Medisch Centrum0 sites100 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
immune system
Sponsor
Radboud Universitair Medisch Centrum
Enrollment
100
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patient population
  • 1\. Have given written informed consent to participate
  • 2\. Be aged 40 years and over
  • 3\. Have symptomatic cerebral small vessel disease defined as:
  • Clinically symptomatic lacunar infarct in presence of white matter
  • hyperintensities (Fazekas \>\=1\) on MRI
  • and/or symptoms of cognitive impairment due to small vessel disease (Fazekas
  • \>\= 1\) with lacunar infarct on MRI
  • and/or gait apraxia/motor impairment presumed due to small vessel disease
  • (Fazekas \>\= 1\) with lacunar infarct on MRI

Exclusion Criteria

  • Patient population
  • \- unable/unwilling to consent including lack of capacity to consent
  • \- vaccination or infection with fever in preceding month
  • \- any stroke cause other than SVD including:
  • o Cardioembolic source
  • o Carotid or vertebral stenosis \>50% measured on NASCET criteria
  • \- Myocardial infarction in past year
  • \- Vasculitis
  • \- any chronic disease that could lead to brain lesions mimicking SVD (for
  • example multiple sclerosis)

Outcomes

Primary Outcomes

Not specified

Similar Trials